Related Experiment Videos
[Bone marrow transplantation for severe aplastic anemia]
E O Bullorsky1, M Bonduel, C Shanley
1Hospital Británico de Buenos Aires, Argentina.
Medicina
|August 26, 1998
Summary
Bone marrow transplantation is a successful treatment for severe aplastic anemia. A conditioning regimen of cyclophosphamide and antilymphocyte globulin effectively prevented graft failure in 20 patients.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Background:
- Severe aplastic anemia (SAA) is a life-threatening hematological disorder with high mortality.
- Bone marrow transplantation (BMT) is the primary treatment for SAA, particularly in younger patients.
- Pre-transplant transfusions are a significant risk factor for graft failure in SAA patients.
Purpose of the Study:
- To evaluate the efficacy of a conditioning regimen for BMT in patients with SAA.
- To assess the incidence of graft failure and patient survival after BMT for SAA.
- To determine if the conditioning regimen is sufficiently myeloablative and immunosuppressive.
Main Methods:
- A cohort of 20 patients with SAA underwent BMT.
- Conditioning regimen consisted of cyclophosphamide combined with antilymphocyte globulin.
- Patients were monitored for engraftment, graft failure, and survival post-transplant.
Main Results:
- All evaluable patients achieved successful engraftment.
- No episodes of graft failure were observed.
- 85% of patients (17 out of 20) are alive with hematopoietic recovery at a median of 27.7 months post-transplant.
Conclusions:
- BMT is an excellent therapeutic option for patients with SAA.
- The conditioning regimen of cyclophosphamide and antilymphocyte globulin effectively prevents graft failure in SAA.
- This regimen is sufficiently myeloablative and immunosuppressive for successful BMT in SAA.